Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-23-021381

Options or other derivatives

  • Sr. VP, R&D & CSO acquired 86,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Or Yat Sun · Sr. VP, R&D & CSO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-11-22 Grant or award : show line 1 in the form Stock Option (right to buy) +86,000 86,000 D
Loading xslF345X05/form4.xml…